SHOCKWAVE MEDICAL INC (SWAV) Stock Price, Forecast & Analysis
NASDAQ:SWAV • US82489T1043
SWAV Key Statistics, Chart & Performance
The current stock price of SWAV is 334.75 USD. In the past month the price increased by 1.49%. In the past year, price increased by 15.77%.
SWAV Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to SWAV. When comparing the yearly performance of all stocks, SWAV is one of the better performing stocks in the market, outperforming 87.72% of all stocks.
SWAV Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SWAV. SWAV has an excellent financial health rating, but there are some minor concerns on its profitability.
SWAV Financial Highlights
Over the last trailing twelve months SWAV reported a non-GAAP Earnings per Share(EPS) of 4.28. The EPS increased by 12.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.76% | ||
| ROA | 9.95% | ||
| ROE | 21.76% | ||
| Debt/Equity | 0.97 |
SWAV Forecast & Estimates
16 analysts have analysed SWAV and the average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75.
For the next year, analysts expect an EPS growth of 36.11% and a revenue growth 27.69% for SWAV
SWAV Ownership
SWAV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.54 | 195.119B | ||
| ISRG | INTUITIVE SURGICAL INC | 49.31 | 179.003B | ||
| SYK | STRYKER CORP | 25.15 | 145.408B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.29 | 110.604B | ||
| BDX | BECTON DICKINSON AND CO | 11.77 | 52.82B | ||
| IDXX | IDEXX LABORATORIES INC | 42.9 | 50.758B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.83 | 46.296B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 38.388B | ||
| RMD | RESMED INC | 21.1 | 37.749B | ||
| DXCM | DEXCOM INC | 28.94 | 28.503B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SWAV
Company Profile
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 1,001 full-time employees. The company went IPO on 2019-03-07. The firm is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. The company provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).
Company Info
SHOCKWAVE MEDICAL INC
5403 Betsy Ross Dr
Santa Clara CALIFORNIA 95054 US
CEO: Douglas Godshall
Employees: 1001
Phone: 15102794262
SHOCKWAVE MEDICAL INC / SWAV FAQ
What does SWAV do?
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 1,001 full-time employees. The company went IPO on 2019-03-07. The firm is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. The company provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).
What is the current price of SWAV stock?
The current stock price of SWAV is 334.75 USD. The price decreased by -0.02% in the last trading session.
Does SWAV stock pay dividends?
SWAV does not pay a dividend.
How is the ChartMill rating for SHOCKWAVE MEDICAL INC?
SWAV has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the growth outlook for SHOCKWAVE MEDICAL INC?
The Revenue of SHOCKWAVE MEDICAL INC (SWAV) is expected to grow by 27.69% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.